Poseida Therapeutics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2024 to a ratio of 12.52, above the company average. This is a clear sign of healthy business climate in the Biotechnology & Pharmaceuticals industry and improving liquidity at their respective customers, during the third quarter 2024. Average receivable collection period, for the Poseida Therapeutics Inc in Sep 30 2024 quarter, has decreased to 29 days, compared to 43 days, in the Jun 30 2024 quarter.

If we take a look into Healthcare sector 266 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2024 from 1910 to 1919.

What is Receivable Turnover Ratio?
What is Poseida Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PSTX Receivables Turnover Ratio	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter
Y / Y Receivable Change	70.08 %	4.38 %	42.55 %	-0.86 %	-77.46 %
Y / Y Revenue Change	667.19 %	29.78 %	172.09 %	148.68 %	-91.96 %
Receivable Turnover Ratio (TTM)	12.52	8.4	7.93	6.81	5.22
PSTX's Total Ranking	# 1919	# 1910	# 888	# 1905	# 3051
Accounts Receivable average collection period days	29	43	46	54	70
Seq. Receivable Change	18.69 %	3.33 %	33.49 %	3.9 %	-27.16 %
Seq. Revenue Change	176.24 %	-7.71 %	12.59 %	167.27 %	-53.27 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 14
Healthcare Sector	# 267
Overall Market	# 1919

Receivable Turnover Ratio Statistics
High	Average	Low
0.55	0.38	0.17
(Sep 30 2022)		(Sep 30 2023)

PSTX Company Profile • Back to PSTX Efficiency Comparisons • Compare PSTX Receivables Turnover Ratio to its Competitors

Financial Statements
Poseida Therapeutics Inc 's Accounts Receivable	$ 15 Millions	Visit PSTX's Balance sheet
Poseida Therapeutics Inc 's Sales TTM	$ 151 Millions	Visit PSTX's Income Statement
Sources of PSTX's Revenues		Visit PSTX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PSTX's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PSTX's Growth Rates	PSTX's Roa	PSTX's Inventory Turnover Ratio	PSTX's Dividend Comparisons
PSTX's Profitability Ratios	PSTX's Roi	PSTX's Asset Turnover Ratio	PSTX's Dividend Growth
PSTX's Valuation Ratios	PSTX's Roe	PSTX's Financial Strength Ratios	PSTX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2024	Receivable at quarter ending Sep 30 2024
Sonida Senior Living Inc	27.68	$ 278.115 Millions	$ 10.046 Millions
Renalytix Plc	27.67	$ 2.352 Millions	$ 0.085 Millions
Neuraxis Inc	27.03	$ 2.456 Millions	$ 0.091 Millions
Marpai Inc	26.21	$ 30.093 Millions	$ 1.148 Millions
Adaptimmune Therapeutics Plc	25.59	$ 175.041 Millions	$ 6.841 Millions
Recursion Pharmaceuticals Inc	24.89	$ 65.184 Millions	$ 2.619 Millions
Lineage Cell Therapeutics Inc	23.85	$ 8.719 Millions	$ 0.366 Millions
Agenus Inc	23.56	$ 160.428 Millions	$ 6.810 Millions
Kymera Therapeutics Inc	23.35	$ 87.563 Millions	$ 3.750 Millions
Editas Medicine Inc	22.87	$ 61.758 Millions	$ 2.701 Millions
Bespoke Extracts Inc	22.31	$ 1.080 Millions	$ 0.048 Millions
Cytomx Therapeutics Inc	22.28	$ 126.617 Millions	$ 5.684 Millions
One World Products Inc	22.21	$ 0.003 Millions	$ 0.000 Millions
Innovative Eyewear Inc	21.65	$ 1.562 Millions	$ 0.072 Millions
Ethema Health Corporation	21.31	$ 5.675 Millions	$ 0.266 Millions
Co diagnostics Inc	19.94	$ 7.321 Millions	$ 0.367 Millions
Nutriband Inc	19.66	$ 2.022 Millions	$ 0.103 Millions
Medinotec Inc	19.03	$ 8.385 Millions	$ 0.441 Millions
Kiniksa Pharmaceuticals International Plc	18.60	$ 384.098 Millions	$ 20.650 Millions
Pulmatrix Inc	18.56	$ 10.005 Millions	$ 0.539 Millions
Milestone Scientific Inc	18.54	$ 8.862 Millions	$ 0.478 Millions
Hookipa Pharma inc	17.97	$ 49.999 Millions	$ 2.782 Millions
Vireo Growth Inc.	17.70	$ 98.534 Millions	$ 5.568 Millions
Macrogenics Inc	17.38	$ 141.329 Millions	$ 8.132 Millions
Silence Therapeutics Plc	17.27	$ 43.010 Millions	$ 2.490 Millions
Innovage Holding Corp	17.01	$ 786.512 Millions	$ 46.249 Millions
Talkspace Inc	16.98	$ 179.853 Millions	$ 10.591 Millions
Scorpius Holdings inc	16.51	$ 10.044 Millions	$ 0.608 Millions
Arvinas Inc	16.48	$ 161.100 Millions	$ 9.775 Millions
Stablecoin Development Corporation	16.33	$ 11.199 Millions	$ 0.686 Millions

Date modified: 2026-08-29T17:42:00+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.